Evidence map›Paper›PMID 29649765›Full record

ReviewCurrent opinion in neurobiology2018

Probing the brain with molecular fMRI.

Souparno Ghosh, Peter Harvey, Jacob C Simon, Alan Jasanoff

Abstract readReview
In one paragraph

Review in Current opinion in neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Probing nitric oxide signaling using molecular MRI.Free radical biology & medicine · 2022
    Review
  6. Reporter Genes for Brain Imaging Using MRI, SPECT and PET.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Molecular fMRI of neurochemical signaling.Journal of neuroscience methods · 2021
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Neurotransmitter-Responsive Nanosensors forJournal of the American Chemical Society · 2019
    Article
  15. Early detection and monitoring of cerebral ischemia using calcium-responsive MRI probes.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  16. Article
  17. Article
  18. Multi-Modal Nano Particle Labeling of Neurons.Frontiers in neuroscience · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Souparno GhoshDepartment of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Rm. 16-561, Cambridge, MA 02139, United States.
Peter HarveyDepartment of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Rm. 16-561, Cambridge, MA 02139, United States.
Jacob C SimonDepartment of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Rm. 16-561, Cambridge, MA 02139, United States.
Alan JasanoffDepartment of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Rm. 16-561, Cambridge, MA 02139, United States; Department of Brain & Cognitive Sciences, Massachusetts Institute of Technology, 77 Massachusetts Ave., Rm. 16-561, Cambridge, MA 02139, United States; Department of Nuclear Science & Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Rm. 16-561, Cambridge, MA 02139, United States. Electronic address: jasanoff@mit.edu.

Funding

Molecular imaging of dopaminergic signaling in rodent brainR01DA038642 · NIDA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JASANOFF, ALAN · 2015 to 2019
$2.8M
Genetically-targeted hemodynamic functional imagingU01NS103470 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JASANOFF, ALAN · 2017 to 2019
$1.6M
Supplement to Neurobiological Engineering Training ProgramT32EB019940 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JASANOFF, ALAN · 2015 to 2025
$1.4M
Toward functional molecular neuroimaging using vasoactive probes in human subjects.R24MH109081 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JASANOFF, ALAN · 2015 to 2017
$1.3M
Nanoprobes for neurotransmitter-sensitive molecular fMRI in addiction researchR21DA044748 · NIDA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JASANOFF, ALAN · 2017 to 2018
$387k
Howard Hughes Medical InstituteNIBIB NIH HHS T32 EB019940NIDA NIH HHS R01 DA038642NIDA NIH HHS R21 DA044748NIMH NIH HHS R24 MH109081NINDS NIH HHS U01 NS103470Wellcome Trust
6 · The paper itself

Abstract

One of the greatest challenges of modern neuroscience is to incorporate our growing knowledge of molecular and cellular-scale physiology into integrated, organismic-scale models of brain function in behavior and cognition. Molecular-level functional magnetic resonance imaging (molecular fMRI) is a new technology that can help bridge these scales by mapping defined microscopic phenomena over large, optically inaccessible regions of the living brain. In this review, we explain how MRI-detectable imaging probes can be used to sensitize noninvasive imaging to mechanistically significant components of neural processing. We discuss how a combination of innovative probe design, advanced imaging methods, and strategies for brain delivery can make molecular fMRI an increasingly successful approach for spatiotemporally resolved studies of diverse neural phenomena, perhaps eventually in people.

Indexed as

Brain MappingAnimalsBrainHumansMagnetic Resonance ImagingMolecular Imaging

Identifiers

PMID29649765
PMCPMC6084488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.